XieR., LiJ., ZhangH., WangL.- mei, HuangC.- rong, and ChenL.- wen. “Total Serum Bile Acids Predict Therapy for HBeAg-Negative Chronic Hepatitis B Patients With Borderline ALT and High HBV DNA”. The Journal of Infection in Developing Countries, Vol. 16, no. 08, Aug. 2022, pp. 1336-42, doi:10.3855/jidc.15915.